Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jian-ang Li"'
Autor:
Ning Pu, Guochao Zhao, Hanlin Yin, Jian-ang Li, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Dayong Jin, Wenhui Lou, Wenchuan Wu
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-13 (2018)
Abstract Background The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy. Immunotherapy has had robust performance against several malignancies, including PDAC. In this study, we
Externí odkaz:
https://doaj.org/article/43c054cfd17349709f2029e712fcd4be
Autor:
Zi-jin Xu, Jian-ang Li, Ze-yuan Cao, Hua-xiang Xu, Ying Ying, Zhi-hang Xu, Run-jie Liu, Yuquan Guo, Zi-xin Zhang, Wen-quan Wang, Liang Liu
Publikováno v:
International Journal of Surgery; Jun2024, Vol. 110 Issue 6, p3591-3605, 15p
Autor:
Jian-ang Li, Yefei Rong, Yuan Ji, Xuefeng Xu, Chen Wf, Wentao Zhou, Pingping Chen, Wei Chen, Yang Lv, Xu Han, Wenhui Lou
Publikováno v:
Pancreas. 49:514-523
OBJECTIVE The genetic aberrations that underlie chromatin remodeling in sporadic nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) remain largely unknown. Here, we investigated the dysregulation of the switch/sucrose nonfermentable (SWI/SNF)
Publikováno v:
Cell Cycle
MLN4924 inhibits the proteolytic degradation of Cullin-Ring E3 ligase (CRL) substrates and exhibits antitumor activity toward various malignancies, including pancreatic cancer. MLN4924 suppresses tumor growth by altering various key regulator protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7427ba46c0b9af786dee0851f930e4
https://europepmc.org/articles/PMC8837228/
https://europepmc.org/articles/PMC8837228/
Autor:
Wenchuan Wu, Jian ang Li, Tiantao Kuang, Xuefeng Xu, Dansong Wang, Yefei Rong, Wenhui Lou, Lei Zhang, Hanlin Yin, Shanshan Gao, Jun Yu, Ning Pu, Yuan Fang, Da-yong Jin
Publikováno v:
Cancer Letters. 460:42-53
Pancreatic ductal adenocarcinoma (PDAC) remains a refractory disease. Programmed cell death protein-1 (PD-1) monotherapy has shown strong performance in targeting several malignancies. However, the effect and mechanism of intrinsic PD-1 in pancreatic
Autor:
Mengmeng Liu, Jian-ang Li, Jianyong Sun, Xu Han, Weixin Wu, Yuan Fang, Ping Zhang, Genwen Chen, Chao Song
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND The aim of this study was to construct a nomogram to predict the prognosis of patients with gastrointestinal stromal tumor (GIST). MATERIAL AND METHODS We enrolled 4086 GIST patients listed in the SEER database from 1998 to 2015. They were
Autor:
Dayong Jin, Abulimiti Nuerxiati, Ning Pu, Wenchuan Wu, Guochao Zhao, Wenhui Lou, Jian-ang Li, Xuefeng Xu, Tiantao Kuang, Hanlin Yin, Dansong Wang
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-13 (2018)
Journal of Translational Medicine
Journal of Translational Medicine
Background The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy. Immunotherapy has had robust performance against several malignancies, including PDAC. In this study, we aim to a
Autor:
Zhi Li, Tiantao Kuang, Yufeng Huang, Lun-Quan Sun, Haiguang Xin, Yefei Rong, Xu Han, Yuan Fang, Jie Gao, Wenhui Lou, Jianlin Chen, Yuezhen Deng, Jian-ang Li
Publikováno v:
Journal of Cellular and Molecular Medicine
Pancreatic cancer is a highly malignant tumour of the digestive tract which is difficult to diagnose and treat. Approximately 90% of cases arise from ductal adenocarcinoma of the glandular epithelium. The morbidity and mortality of the disease have i
Autor:
Ning Pu, Yuan Fang, Guochao Zhao, Jian-ang Li, Wenchuan Wu, Lei Zhang, Wenhui Lou, Hanlin Yin, Abulimiti Nuerxiati, Wanling Lee, Yaolin Xu, Xu Han
Publikováno v:
Cancer Management and Research
Ning Pu,1,2 Jianang Li,1,2 Yaolin Xu,1,2 Wanling Lee,1,2 Yuan Fang,1,2 Xu Han,1,2 Guochao Zhao,1,2 Lei Zhang,1,2 Abulimiti Nuerxiati,1,2 Hanlin Yin,1,2 Wenchuan Wu,1,2 Wenhui Lou1,2 1Department of General Surgery, Zhongshan Hospital, Fudan University
Autor:
Xuefeng Xu, Wenchuan Wu, Wenhui Lou, Tiantao Kuang, Jian-ang Li, Abulimiti Nuerxiati, Ning Pu, Yang Lv, Shanshan Gao, Dansong Wang, Yadong Xu, Lingxiao Liu, Xiaolin Wang, Guochao Zhao
Publikováno v:
Journal of Cancer
Background: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor and the models for survival prediction in PDAC patients after curative resection are still limited. Preoperative alkaline phosphatase-to-albumin ratio (APAR), an origin